Resolutions From The Annual General Meeting Of Novo Nordisk A/S

Published: Mar 19, 2015

Bagsvaerd, Denmark, March 19, 2015 (GLOBE NEWSWIRE) -- Today, Novo Nordisk A/S held its Annual General Meeting, at which the following were adopted:

Financial year 2014 and 2015

The Company's audited Annual Report 2014.
The remuneration of the Board of Directors for 2014 and the level for 2015.
Distribution of profit according to the adopted Annual Report 2014. The dividend will be DKK 5.00 per A and B share of DKK 0.20.

Elections

Re-election of Göran Ando as chairman and Jeppe Christiansen as vice chairman of the Board of Directors.
Re-election of Bruno Angelici, Liz Hewitt, and Thomas Paul Koestler as members of the Board of Directors.
Election of Sylvie Grégoire, Eivind Kolding and Mary Szela as new members of the Board of Directors.
Re-election of PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab as the Company's auditor.

Shares and capital

Reduction of the Company's B share capital by cancellation of part of the Company's own holding of B shares. The Company's B shares are reduced by DKK 10,000,000 from DKK 422,512,800 to DKK 412,512,800.
Authorisation to the Board of Directors until the next Annual General Meeting to allow the Company to repurchase own shares of up to 10% of the share capital subject to a holding limit of 10% of the share capital.

Other

Amendment to the Articles of Association to allow distribution of extraordinary dividend.
Revised Remuneration Principles.

Further information

Company announcement No 19 / 2015

HUG#1904763

Help employers find you! Check out all the jobs and post your resume.

Filter News